Haploidentical Peripheral Blood Stem Cell Transplantation Demonstrates Stable Engraftment in Adults with Sickle Cell Disease.

about

Haploidentical Peripheral Blood Stem Cell Transplantation Demonstrates Stable Engraftment in Adults with Sickle Cell Disease.

Item

http://www.wikidata.org/entity/Q52719334

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Haploidentical Peripheral Bloo ...... ults with Sickle Cell Disease.

@en

Haploidentical Peripheral Bloo ...... ults with Sickle Cell Disease.

@nl

type

Item

label

Haploidentical Peripheral Bloo ...... ults with Sickle Cell Disease.

@en

Haploidentical Peripheral Bloo ...... ults with Sickle Cell Disease.

@nl

prefLabel

Haploidentical Peripheral Bloo ...... ults with Sickle Cell Disease.

@en

Haploidentical Peripheral Bloo ...... ults with Sickle Cell Disease.

@nl

P1476

Haploidentical Peripheral Bloo ...... ults with Sickle Cell Disease.

@en

P2093

Annie L Oh

http://www.w3.org/2001/XMLSchema#string

Damiano Rondelli

http://www.w3.org/2001/XMLSchema#string

David Peace

http://www.w3.org/2001/XMLSchema#string

Irum Khan

http://www.w3.org/2001/XMLSchema#string

John G Quigley

http://www.w3.org/2001/XMLSchema#string

Karen Sweiss

http://www.w3.org/2001/XMLSchema#string

Matthew Koshy

http://www.w3.org/2001/XMLSchema#string

Michel Gowhari

http://www.w3.org/2001/XMLSchema#string

Nadim Mahmud

http://www.w3.org/2001/XMLSchema#string

Pritesh R Patel

http://www.w3.org/2001/XMLSchema#string

P2860

Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel.

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation.

Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype.

HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease.

Long-term outcome and evaluation of organ function in pediatric patients undergoing haploidentical and matched related hematopoietic cell transplantation for sickle cell disease.

HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.

Granulocyte colony-stimulating factor (G-CSF) administration in individuals with sickle cell disease: time for a moratorium?

1994 Consensus Conference on Acute GVHD Grading

Gene Therapy in a Patient with Sickle Cell Disease.

P31

scholarly article

P356

10.1016/J.BBMT.2018.03.031

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29656137

http://www.w3.org/2001/XMLSchema#string

P921

sickle-cell disease

P932

6108914

http://www.w3.org/2001/XMLSchema#string